|Bid||249.60 x 800|
|Ask||257.27 x 900|
|Day's range||251.30 - 257.55|
|52-week range||212.40 - 317.17|
|Beta (5Y monthly)||1.03|
|PE ratio (TTM)||12.11|
|Earnings date||26 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||2.88 (1.11%)|
|Ex-dividend date||17 Aug 2022|
|1y target est||303.69|
BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Laboratory...
Insiders who purchased US$933k worth of Laboratory Corporation of America Holdings ( NYSE:LH ) shares over the past...